![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Antibe Therapeutics Launches Neomem FlexPlus
Antibe Therapeutics Launches Neomem FlexPlus
Citagenix, a subsidiary of Antibe Therapeutics, presented Neomem FlexPlus, which is a high-performance barrier membrane for regenerative procedures in oral surgery.
The device is a single-layer collagen membrane made from porcine peritoneum.
Suture pull-out testing has shown this device membrane to be biomechanically strong yet conformability evaluations prove the ability to adapt to the contour of the surgical site. — Cynthia Jessup
Upcoming Events
-
21Oct